Literature DB >> 16479388

Long-term outcomes of the surgical management of renal cell carcinoma.

John S Lam1, Arie S Belldegrun, Allan J Pantuck.   

Abstract

It has been 35 years since the radical nephrectomy was standardized by the work of Robson et al. (J Urol 101:297-301, 1969). Despite being based on a retrospective review of only 88 cases operated upon over a span of 15 years, this publication was an important milestone in the attempt to create uniformity in the staging of Renal cell carcinoma (RCC), and the measurement of surgical outcomes for RCC. Although this manuscript forms the basis for our contemporary measurement of the long-term results of RCC surgery and set the standard to which the entire subsequent literature was compared, contemporary research subsequently has questioned many of Robson's conclusions regarding RCC. In Robson's era, the majority of patients presented with large, symptomatic tumors, pre-operative staging was imprecise, and many patients had locally advanced disease at the time of surgery: of the 88 patients in Robson's series, 75% were managed through a thoracoabdominal incision. Since that time, advances in renal imaging and clinical staging have led to the increased detection of incidental, lower stage, organ-confined tumors more amendable to expanded surgical options. Surgical techniques have evolved and technological advances have made possible new methods of managing renal tumors in situ that have emphasized a transition from radical to less extirpative approaches. In addition, understanding of the basic biology and genetics of kidney cancer has led to improved prognostication and the development of effective immunotherapies for advanced disease. The current concepts and long-term outcomes of the surgical management of RCC will be reviewed to help elucidate some of these changes, from the evolution of open to laparoscopic to percutaneous, from radical to partial to ablative approaches.

Entities:  

Mesh:

Year:  2006        PMID: 16479388     DOI: 10.1007/s00345-006-0055-5

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  137 in total

1.  Laparoscopic radical nephrectomy in 100 patients: a single center experience from the United States.

Authors:  I S Gill; A M Meraney; D K Schweizer; S S Savage; M G Hobart; G T Sung; D Nelson; A C Novick
Journal:  Cancer       Date:  2001-10-01       Impact factor: 6.860

2.  Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass.

Authors:  Richard E Link; Sam B Bhayani; Mohammed E Allaf; Ioannis Varkarakis; Takeshi Inagaki; Craig Rogers; Li-Ming Su; Thomas W Jarrett; Louis R Kavoussi
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

3.  Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series.

Authors:  Shomik Sengupta; Horst Zincke; Bradley C Leibovich; Michael L Blute
Journal:  BJU Int       Date:  2005-07       Impact factor: 5.588

4.  Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.

Authors:  N B Itano; M L Blute; B Spotts; H Zincke
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

5.  Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology.

Authors:  Douglas S Scherr; Casey Ng; Ravi Munver; R Ernest Sosa; E Darracott Vaughan; Joseph Del Pizzo
Journal:  Urology       Date:  2003-12       Impact factor: 2.649

6.  Prognostic factors in metastatic renal carcinoma.

Authors:  J D Maldazys; J B deKernion
Journal:  J Urol       Date:  1986-08       Impact factor: 7.450

7.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

8.  Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.

Authors:  S A Rosenberg; J C Yang; S L Topalian; D J Schwartzentruber; J S Weber; D R Parkinson; C A Seipp; J H Einhorn; D E White
Journal:  JAMA       Date:  1994 Mar 23-30       Impact factor: 56.272

9.  Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis.

Authors:  Hyung L Kim; Arie S Belldegrun; Danielo G Freitas; Matthew H T Bui; Ken-ryu Han; Frederick J Dorey; Robert A Figlin
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450

10.  Laparoscopic radical nephrectomy: techniques, results and oncological outcome in 125 consecutive cases.

Authors:  Andreas H Wille; Jan Roigas; Serdar Deger; Maximilian Tüllmann; Ingolf Türk; Stefan A Loening
Journal:  Eur Urol       Date:  2004-04       Impact factor: 20.096

View more
  19 in total

1.  Contrast enhanced ultrasound of renal masses.

Authors:  Andre Ignee; Bernd Straub; Gudrun Schuessler; Christoph Frank Dietrich
Journal:  World J Radiol       Date:  2010-01-28

2.  Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction.

Authors:  Sachin Gupta; Venkata Parsa; Lance K Heilbrun; Daryn W Smith; Brenda Dickow; Elisabeth Heath; Ulka Vaishampayan
Journal:  Anticancer Drugs       Date:  2011-09       Impact factor: 2.248

Review 3.  Current Status of Nephron-Sparing Surgery (NSS) in the Management of Renal Tumours.

Authors:  Vivek Venkatramani; Sanjaya Swain; Ramgopal Satyanarayana; Dipen J Parekh
Journal:  Indian J Surg Oncol       Date:  2017-01-30

4.  Clinical symptoms related to renal cell carcinoma are independent prognostic factors for intraoperative complications and overall survival.

Authors:  Attila Szendroi; Adám Tabák; Peter Riesz; Miklós Szucs; Peter Nyírády; Attila Majoros; Gabriel Haas; Imre Romics
Journal:  Int Urol Nephrol       Date:  2009-03-13       Impact factor: 2.370

5.  Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.

Authors:  Juan Chipollini; E Jason Abel; Charles C Peyton; David C Boulware; Jose A Karam; Vitaly Margulis; Viraj A Master; Kamran Zargar-Shoshtari; Surena F Matin; Wade J Sexton; Jay D Raman; Christopher G Wood; Philippe E Spiess
Journal:  Clin Genitourin Cancer       Date:  2017-10-17       Impact factor: 2.872

6.  Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection.

Authors:  Michael E Karellas; Thomas L Jang; Megan A Kagiwada; Michael D Kinnaman; William R Jarnagin; Paul Russo
Journal:  BJU Int       Date:  2008-09-08       Impact factor: 5.588

7.  Safety and efficacy of sorafenib therapy in patients with metastatic kidney cancer with impaired renal function.

Authors:  Venkata Parsa; Lance Heilbrun; Daryn Smith; Aastha Sethi; Ulka Vaishampayan
Journal:  Clin Genitourin Cancer       Date:  2009-08       Impact factor: 2.872

8.  [Value of the postoperative Störkel score. Predict disease-free survival of patients with surgically resected renal cell carcinoma].

Authors:  M May; S Brookman-Amissah; S Pflanz; N Knoll; J Roigas; S Gunia; B Hoschke; F Kendel
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

9.  Oncologic outcome of 132 cases of laparoscopic radical nephrectomy with intact specimen removal for T1-2N0M0 renal cell carcinoma.

Authors:  Ashok K Hemal; Anup Kumar; Narmada P Gupta; Rajeev Kumar
Journal:  World J Urol       Date:  2007-09-05       Impact factor: 4.226

10.  Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy.

Authors:  Leonardo D Borregales; Dae Y Kim; Angie L Staller; Wei Qiao; Arun Z Thomas; Mehrad Adibi; Pheroze Tamboli; Kanishka Sircar; Eric Jonasch; Nizar M Tannir; Surena F Matin; Christopher G Wood; Jose A Karam
Journal:  Urol Oncol       Date:  2015-12-18       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.